A comprehensive view of Injectables/Infusions/IV Drips. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

German firm MorphoSys licenses drugs felzartamab injectable and MOR210 to US biotechnology firm Hibio for US$15M, 15% stake in Hibio; Hibio can develop, market the two drugs worldwide except for felzartamab in China, MOR210 in China, South Korea
Published: June 24, 2022 by SeeNews Pharmaceuticals
FDA approves Rhythm Pharmaceuticals’ Imcivree setmelanotide injectable to treat obesity in patients with Bardet-Biedl syndrome; FDA did not approve drug for patients with Alstroem syndrome
Published: June 23, 2022 by SeeNews Pharmaceuticals
Plus Therapeutics partners with Biocept to use Biocept’s CNSide cerebrospinal fluid assay in ReSPECT-LM Phase 1/2a clinical trial of injectable Rhenium-186 nanoLiposome to treat leptomeningeal metastases, a cancer of brain, spinal cord membranes
Published: June 23, 2022 by GlobeNewswire
Eli Lilly supplying Aveo Oncology with Erbitux cetuximab for North American clinical trial evaluating Aveo’s ficlatuzumab with cetuximab to treat metastatic head, neck squamous cell carcinoma; Merck KGaA providing cetuximab outside of US, Canada
Published: June 23, 2022 by GlobeNewswire
FDA approves Merck’s Vaxneuvance pneumococcal 15-valent conjugate vaccine for children ages 6 weeks to 17 years old; vaccine administered in four-dose series, provides superior immune response against pneumococcal serotype 3, unique serotypes 22F, 33F
Published: June 23, 2022 by Business Wire

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count